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ABSTRACT 
 
Background: Our aim was to determine if changes in ubiquitin are correlated with 
proteins known to be affected directly or indirectly by the ubiquitin-proteasome 
pathway. For example, the intermediary kinase of the NFκβ pathway IKK is tagged 
directly by ubiquitin, aiding its degradation within the large, self-compartmentalised 
protease called the 26S proteasome. IKK degradation allows the release of NFκβ (an 
indirect consequence of ubiquitination) that then translocates into the nucleus to initiate 
the transcription of survival factors such as cIAP2, BCL-XL, BFL1, FLIP, IL-8, and 
TNF-α.  
Methods: Lyophilised baboon endometrial tissues from the University of Illinois at 
Chicago (UIC) and from women undergoing laparoscopy from the Sydney South West 
Area of Health Service (SSWAHS) were processed for RNA extraction and analysis. 
Immunohistochemical studies were also conducted on formalin fixed baboon and 
human endometrial tissues from UIC and from the Sydney West Area Health Service 
(SWAHS). 
Results: IKKα immunostaining were elevated in the cytoplasm of glands during late 
follicular phase and stromal cells during menses in the baboon, whilst proteasome was 
elevated in the nucleus of glands and stroma at menses, as well as within the glandular 
cytoplasm of endometriotic tissues. Comparable levels of Iκβα exists throughout the 
menstrual cycle of the eutopic endometrium, whilst a reduced glandular nuclear Iκβα 
was seen in endometriotic tissues of the animal model. TNF-α was increased within 
stromal cells at menses but was equivalent between the eutopic and ectopic 
 xii 
endometrium. Ubiquitin was similar between LF and mid luteal phase of eutopic glands 
and stroma, as well as between eutopic and ectopic endometrium at mid luteal. IKKβ 
and NFκβ levels were alike within eutopic and ectopic tissues throughout the menstrual 
cycle. In women however, IKKα, IKKβ, Iκβα and NFκβ had comparable levels within 
all cell types and cycle phases, whilst a greater proteasome immunostaining was seen in 
the nucleus of eutopic stromal cells at secretory phase, as well as in the nucleus of 
ectopic stromal cells at proliferative phase. However, the nucleus of stromal cells and 
glandular cytoplasm of endometriotic tissues both had lower proteasome levels during 
the secretory phase. 
Conclusions: In this study, IKKα had a greater potential to activate the p65 subunit of 
NFκβ in ectopic stromal cells than IKKβ and TNF-α did not seem to be correlated with 
greater free ubiquitin expression in endometriosis in the baboon. This suggests that 
IKKα is a likely candidate for ectopic stromal cell survival in endometriosis in the 
animal model but this is unlikely to be mediated by the ubiquitin NFκβ pathway.  
Similarly, in women with endometriosis a different pathway to NFκβ is potentially 
responsible for a greater ectopic cell survival potential, however an increased patient 
cohort is required to definitively ascertain the involvement of IKKα in the future. 
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